(Q46478436)

22 December 2017

title

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study (English)

1 reference

22 December 2017

main subject

diarrhea

0 references

Clostridium difficile

0 references

author name string

Stephen Lewis

series ordinal

1

1 reference

22 December 2017

Stephen Burmeister

series ordinal

2

1 reference

22 December 2017

Jon Brazier

series ordinal

3

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

Clinical Gastroenterology and Hepatology

published in

1 reference

22 December 2017

volume

3

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

442-448

1 reference

22 December 2017

Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

An in-vitro model of colonisation resistance to Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Postantibiotic colonization with Clostridium difficile in nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Is Clostridium difficile endemic in chronic-care facilities?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Resistance of the breast-fed infant to gastroenteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Regulatory effects of bifidobacteria on the growth of other colonic bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Role of intestinal anaerobic bacteria in colonization resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Digestion, excretion, and energy value of fructooligosaccharides in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

The diagnosis of Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of salmonella in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900677-9

7 January 2021

10.1016/S1542-3565(04)00677-9

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

15880313

1 reference

22 December 2017